Post-mortem toxicology: What the dead can and cannot tell us

Journal of Toxicology - Clinical Toxicology

Volumn 41, Issue 1, 2003, Pages 47-56

  Leikin, Jerrold B ^a,c   Watson, William A ^b  

^a Glenbrook Hospital   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c ENH OMEGA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALFENTANIL; ALPRAZOLAM; AMANTADINE; AMFEBUTAMONE; AMOXAPINE; BENZATROPINE; CARBAMAZEPINE; CARBON MONOXIDE; CHLORDIAZEPOXIDE; COCAINE; CODEINE; DEFIBROTIDE; DIFLUNISAL; EPHEDRINE; HYDROCODONE; HYDROXYZINE; LAMOTRIGINE; LORAZEPAM; MIRTAZAPINE; NITRAZEPAM; PHENELZINE; PHENIRAMINE; PHENOBARBITAL; PRIMIDONE; QUINIDINE; QUININE; THEOPHYLLINE; UNINDEXED DRUG; ZOPICLONE;

AUTOPSY; CAUSE OF DEATH; CONFERENCE PAPER; DRUG DETERMINATION; FATALITY; FORENSIC IDENTIFICATION; INTOXICATION;

ANIMALS; AUTOPSY; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POISONING; POSTMORTEM CHANGES; TOXICOLOGY;

CINCHONA PUBESCENS;

EID: 0037287627     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120018270     Document Type: Conference Paper

References (90)

1. Winek CL, Wahba WW, Winek CL Jr., Balzer TX. Drug and chemical blood-level data 2001. Forensic Sci Int 2001; 122:107-123.
2. Karch SB. Alternative strategies for postmortem drug testing. J Anal Toxicol 2001; 25:393-395.
3. Pounder DJ. The nightmare of postmortem drug changes. Legal Medicine 1993, Wecht, CH, New York: Butterworths Legal Publishers, pp. 162-191.
4. Watson WA, Godley PJ, Garriott JC, Bradberry JC, Puckett JD. Blood pentobarbital concentrations during thiopental therapy. Drug Intell Clin Pharm 1986; 20:283-287.
5. Koren G, Klein J. Postmortem redistribution of morphine in rats. Ther Drug Monit 1992; 14:461-463.
6. Logan BK, Smirnow D. Postmortem distribution and redistribution of morphine in man. J Forensic Sci 1996; 41:37-46.
7. Sawyer WR, Forney RB. Postmortem disposition of morphine in rats. Forensic Sci Int 1988; 38:259-273.
8. Shepherd MF, Lake KD, Kamps MA. Postmortem changes and pharmacokinetics: a review of the literature and case report. Ann Pharmacother 1992; 26:510-514.
9. Gomez HF, McKinney PE, Phillips S, Brent J, Watson WA. Postmortem acetaminophen pharmacokinetics: site and time dependent concentration changes. J Forensic Sci 1995; 40:980-982.
10. O'Sullivan JJ, McCarth PV, Wren C. Differences in amiodarone, digoxin, flecainide and sotalol concentrations between antemortem serum and femoral postmortem blood. Hum Exp Toxicol 1995; 14:605-608.
11. Moriya F, Hasimoto Y. Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. J Forensic Sci 1999; 44(1):10-16.
12. Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 1990; 35:243-270.
13. Bailey DN, Shaw RF. Concentrations of basic drugs in postmortem human myocardium. J Toxicol Clin Toxicol 1982; 19:197-202.
14. Dalphe-Scott M, Degouffe M, Garbutt D, Drost M. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. Can Soc For Sci J 1995; 28:113-121.
15. Hilberg T, Rogde S, Marland J. Postmortem drug redistribution-human cases related to results in experimental animals. J Forensic Sci 1999; 44:3-9.
16. Hilberg T, Ripel A, Slordal L, Bjorneboe A, Morland J. The extent of postmortem drug redistribution in a rat model. J Forensic Sci 1999; 44(5):956-962.
17. Baselt RC, ed. Disposition of Toxic Drugs and Chemicals in Man. 6th ed. Foster City, California: Chemical Toxicology Institute, Biomedical Publication, 2002.
18. Pounder DJ, Smith DRW. Postmortem diffusion of alcohol from the stomach. Am J Forensic Med Pathol 1995; 16:89-96.
19. Cook DS, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem blood sample: the influence of postmortem distribution. J Clin Pathol 2000; 5:282-285.
20. Anderson DT, Fritz KL. Quetiapine (Seroquel®) concentrations in seven post-mortem cases. J Anal Toxicol 2000; 24:300-304.
21. Barnhart FE, Fogacci JR, Reed DW. Methamphetamine - a study of postmortem redistribution. J Anal Toxicol 1999; 23:69-70.
22. Anderson DT, Fritz KL, Muto JJ. Distribution of mirtazapine (Remeron®) in thirteen postmortem cases. J Anal Toxicol 1999; 23:544-548.
23. Logan BK, Smirnow D, Gullberg RG. Lack of predictable site-dependent differences and time-dependent changes in postmortem concentrations of cocaine, benzolecgonine, and cocaethylene in humans. J Anal Toxicol 1997; 20:23-31.
24. Kintz P. Interpreting the results of Medico-Legal analysis in cases of substance abuse. J Toxicol Clin Toxicol 2000; 38:197-198.
25. Levine B, Wu SC, Smialek JE. Zolpidem distribution in postmortem cases. J Forensic Sci 1999; 44(2):369-371.
26. Braithwaite RA, Elliott SP, Hale KA. An unusual fatality due to abuse of alfentanil/midazolam mixture. J Toxicol Clin Toxicol 2000; 38:231.
27. Leikin JB, Paloucek FP. Poisoning and Toxicology Handbook. 3rd ed. Hudson, Ohio: Lexi-Comp., 2002:1391-1405.
28. Martin TL. Three cases of fatal paramethoxyamphetamine overdose. J Anal Toxicol 2001; 25:649-651.
29. Levine B, Zhang B, Smialek JE. Citalopram distribution in postmortem cases. J Anal Toxicol 2001; 25:641-644.
30. Rossum KM, Holt G, Robertson MD. Death by strychnine - a case for postmortem redistribution. J Anal Toxicol 2001; 25:382.
31. Kemp PM, Sneed GS, George CE, Distefano RF. Postmortem distribution of nicotine and cotinine from a case involving the simultaneous administration of multiple nicotine transdermal systems. J Anal Toxicol 1997; 21(4):310-313.
32. Levine B, Grieshaber A, Pestaner J, Moore KA, Smialek JE. Distribution of triazolam and alpha-hydroxytriazolam in fatal intoxication case. J Anal Toxicol 2002; 26:52-54.
33. De Letter EA, Clauwaert KM, Lambert WE, Van Bocxlaer JF, De Leenheer AP, Piette MJA. Distribution study of 3,4-methylenedioxy-methamphetamine and 3,4-methylenedioxyamphetamine in a fatal overdose. J Anal Toxicol 2002; 26:113-118.
34. Giroud C, Menetrey A, Augsburger M, Buclin T, Sanchez-Mazas P, Mangin P. Delta (9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentration distribution ratios in blood samples taken from living and dead people. Forensic Sci Int 2001; 123(2-3):159-164.
35. Williams RH, Leikin JB. Medicolegal issues and specimen collection for ethanol testing. Lab Med 1999; 30(8):530-537.
36. Pohland RC, Bernhard NR. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac). J Forensic Sci 1997; 42:812-816.
37. Robertson MD, Drummer OH. Postmortem drug metabolism bacteria. J Forensic Sci 1995; 40:382-386.
38. Robertson MD, Drummer OH. Postmortem distribution and redistribution of nitrobenzodiazepines in man. J Forensic Sci 1998; 43(1):9-13.
39. Winek CL. Reliability of 22-hour postmortem blood and gastric alcohol samples. JAMA 1975; 233:912.
40. Garriott JC, ed. Medicolegal aspects of alcohol. 3rd ed. Tucson, AZ: Lawyers and Judges Publishing Co., 1996:253-266.
41. Jenkins AJ, Lavins ES. 6-Acetylmorphine detection in postmortem cerebro-spinal fluid. J Anal Toxicol 1998; 22:173-175.
42. Moriya J, Hashimoto Y. Determining the state of the deceased during cardiopulmonary resuscitation from tissue distribution patterns of intubation - related lidocaine. J Forensic Sci 2000; 45:846-849.
43. Mackey-Bojack S, Kloss J, Apple F. Cocaine, cocaine metabolite and ethanol concentrations in postmortem blood and vitreous humor. J Anal Toxicol 2000; 24:59-65.
44. Anderson DT, Muto JJ. Duragesic® transdermal patch: postmortem tisuue distribution of fentanyl in 25 cases. J Anal Toxicol 2000; 24:627-634.
45. Gorczynski LY, Melbye FJ. Detection of benzodiazepines in different tissues including bone, using a quanitative ELISA assay. J Forensic Sci 2001; 46(4):916-918.
46. Kalasinsky KS, Dixon MM, Schmunk GA, Kish SJ. Blood, brain and hair GHB concentrations following fatal ingestion. J Forensic Sci 2001; 46(3):728-730.
47. Langford AM, Taylor KK, Pounder DJ. Drug concentration in selected skeletal muscles. J Forensic Sci 1998; 43(1):22-27.
48. Garriott JC. Skeletal muscle as an alternative specimen for alcohol and drug analysis. J Forensic Sci 1991; 36:60-69.
49. Lemos N, Agarwal A. Significance of bile analysis in drug-induced deaths. J Anal Toxicol 1996; 20:61-63.
50. Mazzola CD, Miron S, Jenkins AJ. Loxapine intoxication: case report and literature review. J Anal Toxicol 2000; 24:638-641.
51. Davis G, Park K, Kloss J, Apple F. Tricyclic antidepressant fatality: postmortem tissue concentrations. J Toxicol Clin Toxicol 2001; 39(6):649-650.
52. Levisky JA, Bowerman DL, Jenkins WW, Johnson DG, Karch SD. Drugs in postmortem adipose tissues: evidence of antemortem disposition. Forensic Sci Int 2001; 121:157-160.
53. Hardin GG. Postmortem blood and vitreous human ethanol concentrations in a victim of a fatal motor vehicle crash. J Forensic Sci 2002; 47(2):402-403.
54. Amitai Y. Establishing a cause of death dependent upon time of presentation. J Toxicol Clin Toxicol 2001; 39(6):651-652.
55. Scott KS, Oliver JS. The use of vitreous humor as an alternative to whole blood for the analysis of benzodiazepines. J Forensic Sci 2001; 46(3):694-697.
56. Iten PX, Meir M. Beta-Hydroxybutyric acid - an indicator for an alcoholic ketoacidosis as cause of death in deceased alcohol abusers. J Forensic Sci 2000; 45:624-632.
57. Goeringer KE, Raymon L, Christian GD, Logan BK. Postmortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. J Forensic Sci 2000; 45:633-648.
58. Robertson MD, McMullin MM. Olanzapine concentrations in clinical serum and posmortem blood specimens - when does therapeutic become toxic? J Forensic Sci 2000; 45:418-421.
59. Georinger KE, Raymon L, Logan BK. Postmortem forensic toxicology of trazadone. J Forensic Sci 2000; 45:850-856.
60. Coe JJ. Postmortem chemistry update. Am J Forensic Med Pathol 1993; 14:91-117.
61. Sloop G, Hall M, Simmons GT, Robinson CA. False-positive postmortem EMIT drugs of abuse assay due to lactate dehydrogenase and lactate in urine. J Anal Toxicol 1995; 19:554-556.
62. Uhlin-Hansen U. C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels. Forensic Sci Int 2001; 121:157-160.
63. Simini B. Cherry red discolouration in carbon monoxide poisoning. Lancet 1998; (352):1154.
64. Graeme KA, Wallace KL, Curry SC, Tanen DA, Higgins TJ. Hydrogen Sulfide - induced changes in coin appearance. J Toxicol Clin Toxicol 1998; 36:469-470.
65. Dettling RJ, Briglia EJ, Dal Cortivo LA, Bidanset JH. The production of amitriptyline from nortriptyline in formaldehyde containing solutions. J Anal Toxicol 1990; 14:325-326.
66. Rohrig TP. Comparison of fentanyl concentrations in unembalmed and embalmed liver samples. J Anal Toxicol 1998; 22:253.
67. Tracy TS, Rybeck BF, James DG, Knopp JB, Garnett PM. Stability of benzodiazepines in formaldehyde solutions. J Anal Toxicol 2001; 25:166-173.
68. Skopp G, Potsch L, Klingmann A, Mattern R. stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. J Anal Toxicol 2001; 25:2-7.
69. Cingolani M, Froldi R, Mencarelli R, Mirtella D, Rodriguez D. Detection and quantitation of morphine in fixed tissues and formalin solutions. J Anal Toxicol 2001; 25:31-39.
70. Gannett PM, Hailu S, Daft J, James D, Rybeck B, Tracy TS. In vitro reaction of formaldehyde with fenfluramine: conversion to N-methyl fenfluramine. J Anal Toxicol 2001; 25:88-92.
71. Gannett PM, Daft JR, James D, Rybeck B, Knopp JB, Tracy TS. In vitro reaction of barbiturates with formaldehyde. J Anal Toxicol 2001; 25:443-449.
72. Gransioli MG, Szabo ET, Sunshine I. Detection of methadone as propoxyphene in stored tissues. J Anal Toxicol 1980; 4:46-48.
73. Kunsman GW, Presses CL, Rodriguez P. Carbon monoxide stability in stored postmortem blood samples. J Anal Toxicol 2000; 24:572-578.
74. Koves M, Lawrence K, Mayer JM. Stability of diltiazem in whole blood: forensic implications. J Forensic Sci 1998; 43(3):587-597.
75. LeBeau MA, Montgomery MA, Jufer RA, Miller ML. Elevated GHB in citrate-buffered blood. J Anal Toxicol 2000; 24:383-384.
76. Vesey CT, Langford RM. Stabilization of blood cyanide. J Anal Toxicol 1998; 22:176-178.
77. Darby SM, Miller MI, Allen RO, LeBEau M. A mass spectrometric method for quanitation of intact insulin in blood samples. J Anal Toxicol 2001; 25:8-14.
78. Moriya F, Hashimoto Y. Potential for error when assessing blood cyanide concentrations in fire victims. J Forensic Sci 2001; 46(6):1421-1425.
79. Clauwaert KM, Van Bocxlaer JF, De Leenheer AP. Stability study of the designer drugs "MDA, MDMA and MDEA" in water, serum, whole blood and urine under various storage temperatures. Forensic Sci Int 2001; 124:36-42.
80. Wallace KL, Curry SC. Postcollection rise in methemoglobin level in frozen blood specimens. J Toxicol Clin Toxicol 2002; 40(1):91-94.
81. Kerrigan, S. In vitro production of gamma-hydroxybutyrate in antemortem urine samples. J Anal Toxicol 2002; 26:571-574.
82. Anderson DT, Fritz KL, Muto JJ. Oxycontin: The concept of a "Ghost Pill" amd the post mortem tissue distribution of oxycodone in 36 cases. J Anal Toxicol 2002; 26:448-459.
83. Watson WA, McKinney PE. Necrokinetics: the practical aspects of interpreting postmortem drug concentrations. J Toxicol Clin Toxicol 2001; 39(3):213-214.
84. Raul J-S, Cirimele V, Ludes B, Kintz P. A single therapeutic treatment with betamethasone is detectable in hair. J Anal Toxicol 2002; 26:582-583.
85. Kalasinsky KS, Bosy TZ, Schmunk GA, Ang L, Adams V, Gore SB, Smialek J, Furukawa Y, Guttman M, Dish SJ. Regional distribution of cocaine in postmortem brain of chronic human cocaine users. J Forensic Sci 2000; 45(5):1041-1048.
86. Lemos NP, Anderson RA, Valentini R, Tagliaro F, Scott RTA. Analysis of morphine by RIA and HPLC in fingernail clippings obtained from heroin users. J Forensic Sci 2000; 45(2):407-412.
87. Lester L, Uemura N, Ademola J, Harkey MR, Nath RP, Kim SJ, Jerschow E, Henderson GL, Mendelson J, Jones RT. Disposition of cocaine in skin, interstitial fluid, sebum and stratum corneum J Anal Toxicol 2002; 26:547-553.
88. Jannetto PJ, Wong SH, Gock SB, Laleli-Sahin E, Schur BC, Jentzen JM. Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytchrome P450 for oxycodone cases. J Anal Toxicol 2002; 26:438-447.
89. Spiller HA, Carlisle RD. Timely antemortem and postmortem concentration in a fatal carbamazepine overdose. J Forensic Sci 2001; 46(6):1510-1512.
90. Drummer OH, Gerostamoulos J. Postmortem drug analysis: analytical and toxicological aspects. Ther Drug Monit 2002; 24(2):199-209.